Filing Details

Accession Number:
0000950170-25-042060
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-19 16:32:22
Reporting Period:
2025-03-17
Filing Date:
2025-03-19
Accepted Time:
2025-03-19 16:32:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Achieve Life Sciences Inc. ACHV In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713369 Alistair Richard Stewart 22722 29Th Dr Se
Suite 100
Bothell WA 98021
Chieve Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-17 10,000 $2.86 60,876 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 359 Indirect By Spouse
Common Stock 882 Indirect By Ricanto Limited
Footnotes
  1. In January 2025, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person relinquished the stock option to purchase 67,500 shares of the Issuer's common stock granted on January 13, 2025.
  2. The reporting holder is a principal owner of Ricanto Limited.